Skip to content
healthcare.dev

Bacti Sode

NDC 83027-0152, Bacillus Tetani, Chlamydia Trachomatis, Colibacillinum Cum Natrum Muriaticum, Klebsiella Pneumoniae, Mycobacterium Paratuberculosis, Mycoplasma Pneumoniae, Pneumococcinum, Salmonella Typhi Nosode, Staphylococcus Aureus, Streptococcus Viridans, Pyrogenium, Pertussinum, Streptococcus Agalactiae, Streptococcus Dysgalactiae, Streptococcus Mutans, Bacillus Cereus, spray, from Nutritional Specialties, Inc..

Product NDC
83027-0152
Status
Listed
Labeler
Nutritional Specialties, Inc.
Dosage form
SPRAY
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0152 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLOSTRIDIUM TETANI20 [hp_X]/mL
  • CHLAMYDIA TRACHOMATIS20 [hp_X]/mL
  • ESCHERICHIA COLI20 [hp_X]/mL
  • KLEBSIELLA PNEUMONIAE20 [hp_X]/mL
  • MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS20 [hp_X]/mL
  • MYCOPLASMA PNEUMONIAE20 [hp_X]/mL
  • STREPTOCOCCUS PNEUMONIAE20 [hp_X]/mL
  • SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI20 [hp_X]/mL
  • STAPHYLOCOCCUS AUREUS20 [hp_X]/mL
  • STREPTOCOCCUS VIRIDANS GROUP20 [hp_X]/mL
  • RANCID BEEF20 [hp_X]/mL
  • HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED30 [hp_X]/mL
  • STREPTOCOCCUS AGALACTIAE15 [hp_C]/mL
  • STREPTOCOCCUS DYSGALACTIAE15 [hp_C]/mL
  • STREPTOCOCCUS MUTANS15 [hp_C]/mL
  • BACILLUS CEREUS18 [hp_C]/mL
Package NDCNDC-11Package
83027-0152-18302701520160 mL in 1 BOTTLE, SPRAY (83027-0152-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83027-0152 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0152 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83027-0152. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.